FDA Inspection
Department of Defense - NavyDepartment of Defense - Navy – FDA Inspection, Apr 6, 2011
Record Details
This FDA Inspection record concerns Department of Defense - Navy, with an inspection on April 6, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Department of Defense - Navy
- Inspection Date
- April 6, 2011
- Product Type
- Biologics
View Company Profile
ID · 6ea783ed-2f59-46aa-a88a-8f75d5b768cb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 718393
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)(15)Schedules and procedures for equipment & calibration
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Department of Defense - Navy
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 3, 2025 | VAI | Baltimore District Office | Blood and Blood Products |
| February 10, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 29, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 5, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 9, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Department of Defense - Navy
- FDA Inspection 1271621 - 2025-06-03
- FDA Inspection 1161972 - 2022-02-10
- FDA Inspection 1028666 - 2017-09-29
- FDA Inspection 936422 - 2015-08-05
- FDA Inspection 844205 - 2013-08-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.